Welcome our new residents

The first Robotic radical prostatectomy ⁦TBRH Sciences Centre⁩ and ⁦NOSM University | Université EMNO⁩ was performed today by ⁦Caio Suartz⁩ . We are very happy to have him join our team ⁦NOSMU Urology⁩ We thank ⁦TBRHS Foundation⁩ for supporting the robotic program

This week, we performed the first robotic-assisted radical prostatectomy in Thunder Bay TBRH Sciences Centre . I’m grateful to be part of this committed team of nurses, anesthesiologists, and surgeons. Special thanks to walid shahrour for his leadership and continuous support.

Wei Shen Tan Roberto Contieri Ospedale San Raffaele Marco Moschini Deintensification of treatment for LG IR NMIBC should be considered for all patients. Here in European Urology Oncology we outline our proposed algorithm #EAU25 Wes Kassouf Sarah P. Psutka MD MS Marco Moschini Joan Palou Redorta Paolo Gontero Morgan Roupret Jeremy Teoh Laura S. Mertens Roberto Contieri

#EAU25 Small renal masses Phillip Pierorazio kicked off with an amazing talk, presenting all the data supporting safe patient surveillance Marcelo Wroclawski Wbusato Caio Suartz Carlos Alberto Toledo Martínez Clovis Fraga T. Pereira Paulo Roberto Salustiano Dr. Rafael Mourato @MSdoNascimento Luis Fernando Sala OncoAlert MEDTRACK LARVOL

Honored to work with such dedicated and talented colleagues. Our 2nd place at Uro Onco reflects a true team effort. Congrats to José Neto for his excellent talk on using CT indexes to predict survival and postop outcomes in uro-oncology. Onward and upward! 💪🔬Congresso Internacional de Uro-Oncologia

We want to thank our friends in the media and others who stopped by on April 22nd for a sneak peek at one of our Hospital's newest technological additions.👇🏽

Lack of Evidence-based postoperative recommendations 👉 an unmet need‼️ sciencedirect.com/science/articl… OncoAlert OncoReporte Gil Morgan Dra. María Natalia Gandur Quiroga Jose Fernando Moura, PhD Dr Joseph McCollom DO Deniz Can Guven Biagio Ricciuti, MD PhD Elisa Agostinetto Yakup Ergün Emre Yekedüz Eric K. Singhi, MD

Thank you Philippe spiess for sharing your experience and expertise in Upper Tract Urothelial Carcinoma ✨👏 Marcelo Wroclawski Wbusato Caio Suartz Carlos Alberto Toledo Martínez Clovis Fraga T. Pereira Petros Grivas Paulo Roberto Salustiano Dr. Rafael Mourato @MSdoNascimento Luis Fernando Sala Ana Paula Garcia Cardoso Daniel Vargas Pivato de Almeida fabio schutz

What an honor to have Riccardo Autorino MD PhD FACS in Brazil to discuss the landscape of robotic surgery worldwide #JPU25 Marcelo Wroclawski Wbusato Caio Suartz Carlos Alberto Toledo Martínez Clovis Fraga T. Pereira Paulo Roberto Salustiano Dr. Rafael Mourato @MSdoNascimento Luis Fernando Sala OncoAlert

#ActiveSurveillance for #ProstateCancer in Göteborg-1 Trial ⏩️25 years FU ✨Failure-free survival rate at 22 yr: 68% ✨PC-specific survival rate at 25 yr: 94% ✨PC-specific survival rate at 24 yr: - 99% for very-low-risk - 92% for low-risk - 85% for intermediate-risk

Great food, great company, and of course… great prostate talk! From PSA to pasta — urology never tasted this good. #UrologyLife #ProstateCancerAwareness walid shahrour NOSM University | Université EMNO waleed shabana Caio Suartz

Just published online in Journal of Clinical Oncology : #SunRISe1 Phase IIb results show TAR-200 (novel intravesical drug releasing system) achieves 82.4% CR in BCG-unresponsive high-risk NMIBC—with durable responses (median DOR 25.8 mo) & low toxicity. A game-changer for pts with #NMIBC.

Neoadjuvant Immunotherapy in Bladder Cancer: Ushering in a New Era of Treatment—A Systematic Review of Current Evidence authors.elsevier.com/sd/article/S26…